Yasheng Pharmaceutical (06855): The trustee purchased 200,000 shares for the purpose of the 2022 restricted share unit plan

Zhitongcaijing · 3d ago

According to Zhitong Finance App, Yasheng Pharmaceutical (06855) issued an announcement. On October 15, 2026, the trustee announced that on October 15, 2026, the 2022 restricted share unit plan aims to purchase a total of 200,000 existing shares on the market to satisfy the restricted share units after ownership.